175 related articles for article (PubMed ID: 35725670)
1. Adrenal steroid profiling as a diagnostic tool to differentiate polycystic ovary syndrome from nonclassic congenital adrenal hyperplasia: pinpointing easy screening possibilities and normal cutoff levels using liquid chromatography tandem mass spectrometry.
Ueland GÅ; Dahl SR; Methlie P; Hessen S; Husebye ES; Thorsby PM
Fertil Steril; 2022 Aug; 118(2):384-391. PubMed ID: 35725670
[TBL] [Abstract][Full Text] [Related]
2. Serum 21-Deoxycortisol for Diagnosis of Nonclassic Congenital Adrenal Hyperplasia in Women With Androgen Excess.
Ng JL; Lim EM; Zhang R; Beilby JP; Watts GF; Brown SJ; Stuckey BGA
J Clin Endocrinol Metab; 2023 Nov; 108(12):e1560-e1570. PubMed ID: 37358001
[TBL] [Abstract][Full Text] [Related]
3. Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone.
Oriolo C; Fanelli F; Castelli S; Mezzullo M; Altieri P; Corzani F; Pelusi C; Repaci A; Di Dalmazi G; Vicennati V; Baldazzi L; Menabò S; Dormi A; Nardi E; Brillanti G; Pasquali R; Pagotto U; Gambineri A
J Endocrinol Invest; 2020 Oct; 43(10):1499-1509. PubMed ID: 32236851
[TBL] [Abstract][Full Text] [Related]
4. Screening for non-classic congenital adrenal hyperplasia in women: New insights using different immunoassays.
Nakhleh A; Saiegh L; Shehadeh N; Weintrob N; Sheikh-Ahmad M; Supino-Rosin L; Alboim S; Gendelman R; Zloczower M
Front Endocrinol (Lausanne); 2022; 13():1048663. PubMed ID: 36704043
[TBL] [Abstract][Full Text] [Related]
5. Screening for Nonclassic Congenital Adrenal Hyperplasia in the Era of Liquid Chromatography-Tandem Mass Spectrometry.
Chesover AD; Millar H; Sepiashvili L; Adeli K; Palmert MR; Hamilton J
J Endocr Soc; 2020 Feb; 4(2):bvz030. PubMed ID: 32110745
[TBL] [Abstract][Full Text] [Related]
6. The Short Cosyntropin Test Revisited: New Normal Reference Range Using LC-MS/MS.
Ueland GÅ; Methlie P; Øksnes M; Thordarson HB; Sagen J; Kellmann R; Mellgren G; Ræder M; Dahlqvist P; Dahl SR; Thorsby PM; Løvås K; Husebye ES
J Clin Endocrinol Metab; 2018 Apr; 103(4):1696-1703. PubMed ID: 29452421
[TBL] [Abstract][Full Text] [Related]
7. The diagnosis of nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, based on serum basal or post-ACTH stimulation 17-hydroxyprogesterone, can lead to false-positive diagnosis.
Ambroziak U; Kępczyńska-Nyk A; Kuryłowicz A; Małunowicz EM; Wójcicka A; Miśkiewicz P; Macech M
Clin Endocrinol (Oxf); 2016 Jan; 84(1):23-9. PubMed ID: 26331608
[TBL] [Abstract][Full Text] [Related]
8. Steroid Screening Tools Differentiating Nonclassical Congenital Adrenal Hyperplasia and Polycystic Ovary Syndrome.
Maffazioli GDN; Bachega TASS; Hayashida SAY; Gomes LG; Valassi HPL; Marcondes JAM; Mendonca BB; Baracat EC; Maciel GAR
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32530459
[TBL] [Abstract][Full Text] [Related]
9. LC-MS/MS improves screening towards 21-hydroxylase deficiency.
Ambroziak U; Kępczyńska-Nyk A; Kuryłowicz A; Wysłouch-Cieszyńska A; Małunowicz EM; Bartoszewicz Z; Kondracka A; Jaźwiec R; Pawłowska E; Szcześniak M; Dadlez M; Bednarczuk T
Gynecol Endocrinol; 2015 Apr; 31(4):296-300. PubMed ID: 25539143
[TBL] [Abstract][Full Text] [Related]
10. Genotype-Specific Cortisol Reserve in a Cohort of Subjects With Nonclassic Congenital Adrenal Hyperplasia (NCCAH).
Koren I; Weintrob N; Kebesch R; Majdoub H; Stein N; Naor S; Segev-Becker A
J Clin Endocrinol Metab; 2024 Feb; 109(3):852-857. PubMed ID: 37715965
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families.
Nandagopal R; Sinaii N; Avila NA; Van Ryzin C; Chen W; Finkielstain GP; Mehta SP; McDonnell NB; Merke DP
Eur J Endocrinol; 2011 Jun; 164(6):977-84. PubMed ID: 21444649
[TBL] [Abstract][Full Text] [Related]
12. The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
Pall M; Azziz R; Beires J; Pignatelli D
Fertil Steril; 2010 Jul; 94(2):684-9. PubMed ID: 19726039
[TBL] [Abstract][Full Text] [Related]
13. Superior discriminating value of ACTH-stimulated serum 21-deoxycortisol in identifying heterozygote carriers for 21-hydroxylase deficiency.
Costa-Barbosa FA; Tonetto-Fernandes VF; Carvalho VM; Nakamura OH; Moura V; Bachega TA; Vieira JG; Kater CE
Clin Endocrinol (Oxf); 2010 Dec; 73(6):700-6. PubMed ID: 20846292
[TBL] [Abstract][Full Text] [Related]
14. Steroid profile in dried blood spots by liquid chromatography tandem mass spectrometry: Application to newborn screening for congenital adrenal hyperplasia in China.
Zhan X; Han L; Qiu W; Gu X; Guo J; Chang S; Wang Y; Zhang H
Steroids; 2022 Sep; 185():109056. PubMed ID: 35660382
[TBL] [Abstract][Full Text] [Related]
15. Reassessment of predictive values of ACTH-stimulated serum 21-deoxycortisol and 17-hydroxyprogesterone to identify CYP21A2 heterozygote carriers and nonclassic subjects.
Costa-Barbosa FA; Carvalho VM; Oliveira KC; Vieira JGH; Kater CE
Clin Endocrinol (Oxf); 2021 Oct; 95(4):677-685. PubMed ID: 34231242
[TBL] [Abstract][Full Text] [Related]
16. Combining metabolomics and machine learning models as a tool to distinguish non-classic 21-hydroxylase deficiency from polycystic ovary syndrome without adrenocorticotropic hormone testing.
Bachelot G; Bachelot A; Bonnier M; Salem JE; Farabos D; Trabado S; Dupont C; Kamenicky P; Houang M; Fiet J; Le Bouc Y; Young J; Lamazière A
Hum Reprod; 2023 Feb; 38(2):266-276. PubMed ID: 36427016
[TBL] [Abstract][Full Text] [Related]
17. Basal levels of 17-hydroxyprogesterone can distinguish children with isolated precocious pubarche.
Grandone A; Marzuillo P; Luongo C; Toraldo R; Mariani M; Miraglia Del Giudice E; Perrone L
Pediatr Res; 2018 Oct; 84(4):533-536. PubMed ID: 29976972
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous quantification of 17α-OH progesterone, 11-deoxycortisol, Δ4-androstenedione, cortisol and cortisone in newborn blood spots using liquid chromatography-tandem mass spectrometry.
Magnisali P; Chalioti MB; Livadara T; Mataragas M; Paliatsiou S; Malamitsi-Puchner A; Moutsatsou P
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(19):1565-72. PubMed ID: 21514253
[TBL] [Abstract][Full Text] [Related]
19. Multiplexed steroid profiling of gluco- and mineralocorticoids pathways using a liquid chromatography tandem mass spectrometry method.
Travers S; Martinerie L; Bouvattier C; Boileau P; Lombès M; Pussard E
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):202-211. PubMed ID: 27339652
[TBL] [Abstract][Full Text] [Related]
20. LC-MS/MS based determination of basal- and ACTH-stimulated plasma concentrations of 11 steroid hormones: implications for detecting heterozygote CYP21A2 mutation carriers.
Kulle AE; Riepe FG; Hedderich J; Sippell WG; Schmitz J; Niermeyer L; Holterhus PM
Eur J Endocrinol; 2015 Oct; 173(4):517-24. PubMed ID: 26315375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
